265 related articles for article (PubMed ID: 33201095)
1. Diagnostic Performance of Noninvasive Imaging for Assessment of Axillary Response After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer: A Systematic Review and Meta-analysis.
Samiei S; de Mooij CM; Lobbes MBI; Keymeulen KBMI; van Nijnatten TJA; Smidt ML
Ann Surg; 2021 Apr; 273(4):694-700. PubMed ID: 33201095
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.
Riegger C; Koeninger A; Hartung V; Otterbach F; Kimmig R; Forsting M; Bockisch A; Antoch G; Heusner TA
Acta Radiol; 2012 Dec; 53(10):1092-8. PubMed ID: 23002144
[TBL] [Abstract][Full Text] [Related]
4. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid
de Mooij CM; Samiei S; Mitea C; Lobbes MBI; Kooreman LFS; Heuts EM; Beets-Tan RGH; van Nijnatten TJA; Smidt ML
Clin Radiol; 2022 Oct; 77(10):e732-e740. PubMed ID: 35850866
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Different Surgical Procedures for Axillary Staging After Neoadjuvant Systemic Therapy in Node-positive Breast Cancer: A Systematic Review and Meta-analysis.
Simons JM; van Nijnatten TJA; van der Pol CC; Luiten EJT; Koppert LB; Smidt ML
Ann Surg; 2019 Mar; 269(3):432-442. PubMed ID: 30312200
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive nodal restaging in clinically node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review.
Schipper RJ; Moossdorff M; Beets-Tan RGH; Smidt ML; Lobbes MBI
Eur J Radiol; 2015 Jan; 84(1):41-47. PubMed ID: 25458227
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional imaging to evaluate the extent of regional nodal disease in breast cancer patients undergoing neoadjuvant systemic therapy.
Anderson TL; Glazebrook KN; Murphy BL; Viers LD; Hieken TJ
Eur J Radiol; 2017 Apr; 89():163-168. PubMed ID: 28267534
[TBL] [Abstract][Full Text] [Related]
9. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
[TBL] [Abstract][Full Text] [Related]
11. Value of
de Mooij CM; Mitea C; Mottaghy FM; Smidt ML; van Nijnatten TJA
EJNMMI Res; 2021 Nov; 11(1):116. PubMed ID: 34807395
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Jun; 45(6):969-975. PubMed ID: 30744944
[TBL] [Abstract][Full Text] [Related]
13. Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysis.
Samiei S; Simons JM; Engelen SME; Beets-Tan RGH; Classe JM; Smidt ML;
JAMA Surg; 2021 Jun; 156(6):e210891. PubMed ID: 33881478
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Li Z; Ma Q; Gao Y; Qu M; Li J; Lei J
Eur Radiol; 2024 Feb; 34(2):930-942. PubMed ID: 37615764
[TBL] [Abstract][Full Text] [Related]
15. Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Koolen BB; Valdés Olmos RA; Wesseling J; Vogel WV; Vincent AD; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Vrancken Peeters MJ
Ann Surg Oncol; 2013 Jul; 20(7):2227-35. PubMed ID: 23456316
[TBL] [Abstract][Full Text] [Related]
16. Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients.
Dulgeroglu O; Arikan AE; Capkinoglu E; Kara H; Uras C
Ann Ital Chir; 2022; 93():648-655. PubMed ID: 36617275
[TBL] [Abstract][Full Text] [Related]
17. Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.
Koolen BB; Donker M; Straver ME; van der Noordaa MEM; Rutgers EJT; Valdés Olmos RA; Vrancken Peeters MJTFD
Br J Surg; 2017 Aug; 104(9):1188-1196. PubMed ID: 28524246
[TBL] [Abstract][Full Text] [Related]
18. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
[TBL] [Abstract][Full Text] [Related]
20. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
